Results (4101)
TAK-633-4008: Quantitative Testing of Patient and Prescriber Knowledge, Attitudes, and Behavior about GATTEX (Teduglutide) for Injection Safety and Use Information (GATTEX KAB)
United States
EU PAS number:
EUPAS48716
First published:
15/10/2024
StudyOngoing
An observational study to evaluate the long-term effects of evinacumab treatment in patients with homozygous familial hypercholesterolemia (HoFH)
Austria
Brazil
Canada
France
Germany
Italy
Japan
Mexico
Netherlands
Portugal
Spain
EU PAS number:
EUPAS47088
First published:
15/10/2024
StudyOngoing
Long Term Post Marketing Drug Use Result Survey for Blinatumomab in Japan (20180238) (Blinatumomab Long Term PMS Japan)
Japan
EU PAS number:
EUPAS29685
First published:
15/10/2024
StudyOngoing
An observational study of blinatumomab safety and effectiveness, utilisation, and treatment practices (20150136)
Austria
Czechia
Finland
France
Germany
Greece
Italy
Netherlands
Poland
Portugal
Sweden
Switzerland
United Kingdom
EU PAS number:
EUPAS17848
First published:
15/10/2024
StudyOngoing
Use of Erythropoiesis Stimulating Agents (ESAs) in Patients Receiving Myelosuppressive Chemotherapy in Europe and the UK (20190404)
Belgium
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS49757
First published:
15/10/2024
StudyOngoing
WAYLIVRA® Post-Authorisation Safety Study (PASS) and Product Registry (WAY4001)
Austria
France
Germany
Greece
Italy
Netherlands
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS36702
First published:
15/10/2024
StudyOngoing
A Retrospective, Non-interventional, Multi-centre Study of TEGSEDI-treated Patients to Evaluate Real-world Adherence to, and Effectiveness of the Recommendations for Platelet Monitoring, Dose Adjustment, and Steroid Initiation to Manage Risk of Thrombocytopenia (TEG4002)
Austria
Bulgaria
Cyprus
France
Germany
Greece
Italy
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS37731
First published:
15/10/2024
StudyPlanned
WINE Study: Roxadustat Treatment of Anemia of Chronic Kidney Disease (CKD) in Real-world Clinical Practice - Observational Study Utilizing Routinely Collected Secondary Data from WiNe Registry in Germany
Germany
EU PAS number:
EUPAS1000000121
First published:
15/10/2024
StudyOngoing
Comparative effectiveness of sotorasib versus docetaxel in second line and beyond (2L+) among patients with advanced non-small cell lung cancer (NSCLC) in the Flatiron Health (FH) Enhanced Datamart (EDM)
United States
EU PAS number:
EUPAS1000000056
First published:
15/10/2024
StudyOngoing
Brigatinib-5007: A Cohort Study to Describe the Occurrence of Early-Onset Pulmonary Events in Patients with Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Treated with Brigatinib: A Post-Authorisation Safety Study
Austria
Denmark
Finland
France
Germany
Ireland
Netherlands
Norway
Sweden
United Kingdom
EU PAS number:
EUPAS32383
First published:
15/10/2024
StudyFinalised
Association between exposure to liraglutide versus active comparators and risk of acute hepatic injury
Germany
United Kingdom
EU PAS number:
EUPAS1000000243
First published:
14/10/2024
StudyFinalised
Development and validation of a risk prediction tool for oral corticosteroid adverse outcomes in asthma, based on real-world exposure information
United Kingdom
EU PAS number:
EUPAS1000000336
First published:
14/10/2024
StudyPlanned
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
United States
EU PAS number:
EUPAS1000000334
First published:
14/10/2024
StudyOngoing
A Post-Marketing Safety Study using a Pregnancy Registry to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy (C3671041)
United States
EU PAS number:
EUPAS1000000179
First published:
14/10/2024
StudyPlanned
A drug utilisation study to assess the effectiveness of risk minimisation measures and describe the prescribing practices of Doreta SR and tramadol/paracetamol combinations in Europe (DUS Doreta SR and tramadol/paracetamol combination)
Czechia
Hungary
Poland
EU PAS number:
EUPAS47961
First published:
14/10/2024
StudyFinalised
GIPAM GmbH
Germany
United Kingdom
United States
First published:
10/10/2024
Institution
OtherENCePP partnerA Retrospective Cohort Study to Characterize Patient Characteristics and Treatment Outcomes Among Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) in the French Epidemiological Strategy and Medical Economics Advanced or Metastatic Lung Cancer (ESME-AMLC) Database (20190402)
France
EU PAS number:
EUPAS40706
First published:
08/10/2024
StudyOngoing
Pregnancy and Neonatal Outcomes following Prenatal Exposure to Cabotegravir: Data from The Antiretroviral Pregnancy Registry (APR) (215325)
Czechia
France
EU PAS number:
EUPAS45685
First published:
07/10/2024
StudyOngoing
219111- A retrospective matched cohort database study in the United States to evaluate the effectiveness of recombinant zoster vaccine (RZV) in patients with autoimmune diseases (AIDs) (EPI-ZOSTER-097 VE US DB)
United States
EU PAS number:
EUPAS49294
First published:
07/10/2024
StudyOngoing
Post-Authorization Safety Study Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine (DNG15-Post Authorisation safety Surveillance study)
Brazil
Mexico
Philippines
EU PAS number:
EUPAS28947
First published:
04/10/2024
StudyFinalised
An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using Health Insurance Databases in the United States
United States
EU PAS number:
EUPAS49836
First published:
04/10/2024
StudyOngoing
Terveydenhuollon hoitoilmoitusrekisteri (Finland Care Register for Health Care)
Finland
First published:
04/10/2024
Data source
Emergency care discharge recordsHospital discharge recordsHospital inpatient recordsHospital outpatient visit recordsSpecialist ambulatory care recordsAssociation between exposure to esomeprazole/omeprazole and risk of sexual dysfunction in men
Germany
United Kingdom
EU PAS number:
EUPAS1000000242
First published:
04/10/2024
StudyOngoing
DARWIN EU® - Antipsychotic prescribing in older people in Europe: a descriptive analysis of trends and patient characteristics
Belgium
Croatia
Denmark
Germany
Netherlands
Spain
EU PAS number:
EUPAS1000000330
First published:
04/10/2024
StudyOngoing
Drug utilization of biological drugs in patients over 65 years with Immune- mediated inflammatory diseases through the Italian VALORE network
Italy
EU PAS number:
EUPAS1000000211
First published:
04/10/2024
StudyPlanned
A Post-Marketing, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Individuals Exposed to Omaveloxolone During Pregnancy and/or Lactation
United States
EU PAS number:
EUPAS1000000327
First published:
04/10/2024
StudyPlanned
An Observational, Multinational, Post-Marketing Registry of Omaveloxolone-Treated Patients With Friedreich’s Ataxia
United States
EU PAS number:
EUPAS1000000196
First published:
04/10/2024
StudyPlanned
DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
Croatia
Denmark
France
Germany
Portugal
Spain
United Kingdom
EU PAS number:
EUPAS1000000329
First published:
04/10/2024
StudyOngoing
Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment
Italy
EU PAS number:
EUPAS1000000328
First published:
04/10/2024
StudyFinalised
A multicenter evaluation of the treatment persistence of advanced therapies (Biological disease-modifying agents and Targeted synthetic Disease Modifying Anti-Rheumatic Drugs) in the treatment of rheumatoid arthritis (RA): A Real World Evidence (RWE) study from India
India
EU PAS number:
EUPAS103727
First published:
04/10/2024
StudyOngoing
Pregnancy Surveillance Program of Women and Infants Exposed to TEGSEDI During Pregnancy (TEG4005)
Austria
Bulgaria
Canada
Cyprus
France
Germany
Greece
Italy
Portugal
Spain
Sweden
United Kingdom
United States
EU PAS number:
EUPAS41839
First published:
03/10/2024
StudyPlanned
A Prospective, Non-interventional, Long-term, Multinational Cohort Safety Study of Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy (hATTR-PN) (TEG4001)
Bulgaria
Canada
Cyprus
France
Germany
Greece
Italy
Portugal
Spain
United Kingdom
United States
EU PAS number:
EUPAS37728
First published:
03/10/2024
StudyOngoing
A prospective, non-interventional study in female patients with moderate to severe active rheumatoid arthritis in France receiving filgotinib for 2 years (PARROTFISH)
France
EU PAS number:
EUPAS46020
First published:
01/10/2024
StudyOngoing
id.DRIVE study of brand-specific respiratory syncytial virus (RSV) vaccine effectiveness in Europe
France
Germany
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000035
First published:
01/10/2024
StudyOngoing
Semmelweis University Clinical Data
Hungary
First published:
30/09/2024
Data source
Hospital inpatient recordsHospital outpatient visit recordsOtherAn Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)® (Voxelotor)
United States
EU PAS number:
EUPAS1000000170
First published:
30/09/2024
StudyOngoing
Postauthorisation Safety Study (PASS) of Avatrombopag and Haematological Malignancies in Patients With Primary Immune Thrombocytopaenia
Denmark
Sweden
EU PAS number:
EUPAS1000000315
First published:
30/09/2024
StudyPlanned
Avelumab in real-world treatment of urothelial cancer – The AVENUE NIS
Germany
Russian Federation
Spain
Switzerland
EU PAS number:
EUPAS42413
First published:
30/09/2024
StudyOngoing